NeoCare Inc. founded in 2021 is developing non-invasive techniques disease detection in new born in a cost-effective manner.
Problem Statement: Neonatal jaundice, anemia and hypoxia are the most common health issues encountered by newborns globally and constitute a major percentage of infant mortality. The prevalence of neonatal jaundice anemia and hypoxia is quoted to be between 50% and 60% among healthy term neonates. Similarly, 42% babies born are affected with anemia.
Read MoreMultiple needle punctures for new born
Emotional stress for the babies and parents
Blood test reports are not instantaneous. Time investment is substantial
Maintenance of costly laboratory equipment and trained technical personnel
Neocare, No stress no duress
We Provide painless blood parameter without needle puncture
Result are right away
Three times less costly compared to lab test cost
No kit, no strips
Neo Care Team
Senior Professor. Part of Noble winning group 400 publications. 40 patents. Multiple awards and accolades.
Senior Professor. Head Neo-Natal ICU Aggressive researcher.
+1 647 870 9275
soumendras@gmail.com
